Therefore, on the basis of our analysis, we propose new clinicopathological definitions using 20% as a threshold for Ki-67 to distinguish the luminal A and luminal B intrinsic molecular breast cancer subtypes. This evidence concerns the gene MKI67 and breast carcinoma.